Blog

Sharesight20ASX top 20 ASX trades - 8th October 2019

by David Olsen, Senior Marketing Manager — Content/SEO, Sharesight | Oct 7th 2019
Disclaimer: The below article is for informational purposes only and does not constitute a product recommendation, or taxation or financial advice and should not be relied upon as such. Please check with your adviser or accountant to obtain the correct advice for your situation.

We're a day later with this week's update due to the public holiday in Australia Monday this week.

Last week Sharesight users jumped on medical small cap Actinogen Medical (ASX: ACW) after the company announced positive study results for their Alzheimer’s drug Xanamem. Some users also sold down Nufarm limited to realise some gains after the stock shot up 42% in the last week of September.

Top 20 ASX trades last week

Click for the full Sharesight20ASX:

Top20 ASX trades October 1st 2019)

Subscribe to Sharesight20 snapshots

Did you know you can receive Sharesight20 trading snapshots by email automatically? Subscribe here to always get the latest data when it's released.

Track your investment portfolio with Sharesight

Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:

Sign up for a FREE Sharesight account and get started tracking your investments today.

FURTHER READING

Bull market investing

What bull markets hide from investors

by Marcus Padley | Oct 8th 2025

Bull markets make every strategy look smart — until they end. Learn what they hide and how to protect your portfolio when the trend reverses.

Sharesight exposure report

See what’s inside your ETFs with Sharesight’s exposure report

by Stephanie Stefanovic | Oct 3rd 2025

Understand your true portfolio exposure, see what’s inside your ETFs and make informed decisions with Sharesight’s exposure report.

Financial advisers top client mistakes

Top 10 mistakes financial advisers make with their clients

by Stephanie Stefanovic | Oct 3rd 2025

In this article, we discuss the 10 most common mistakes that financial advisers make with their clients (and how to avoid them).